Hurley Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1
Closed -$8.37K 727
2025
Q4
$8.37K Buy
+1
New +$956 ﹤0.01% 351

Other funds holding LLY

Hurley Capital's LLY Position: Q1 2026 in Review

Hurley Capital increased its Eli Lilly (LLY) stake by 0.76% in Q1 2026, buying an estimated $1.01K and bringing the position to 132 shares worth $122K. The position accounts for 0.07% of the portfolio, ranked #115.

Hurley Capital first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $162K in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Hurley Capital held 132 shares of Eli Lilly worth $122K as of Q1 2026.
  • Hurley Capital bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.07% of Hurley Capital's portfolio in Q1 2026, its #115 holding.
  • Hurley Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Hurley Capital's Eli Lilly position peaked at $162K in Q4 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.